POZ - African American Hub : Treatment News : Preterm Delivery, Low Birth Weight Unlikely with Perinatal HIV Treatment

POZ African American / Black Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
|
|
|
|
|
|
|
|
|
African American Hub News
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007


emailrssprint

June 19, 2009

Preterm Delivery, Low Birth Weight Unlikely with Perinatal HIV Treatment

HIV treatment does not increase the risk of preterm delivery, according to a French research analysis involving more than 8,000 HIV-negative babies born to HIV-positive women over a 16-year period. The new data, published June 19 in AIDS, dispel other reports suggesting that antiretroviral (ARV) therapy, notably protease inhibitors, affects fetal development and results in low birth weight.

Ever since short-term Retrovir (zidovudine) was proved to significantly reduce the risk of an HIV-infected mother passing on the virus to her child, there have been concerns about whether this ARV treatment could negatively affect the baby. Some studies have suggested that HIV drug regimens used during pregnancy, notably those including protease inhibitors, might increase the risk of premature births or babies born with lower-than-normal birth weight. Other studies, however, did not reach the same conclusions.

Nelly Briant, MD, from the Kremlin Bicêtre Hospital in Paris and her colleagues theorized the studies that did find an increased risk of preterm delivery were flawed in their design, failing to take into account certain risk factors known to be associated with preterm births, such as babies actually born with HIV infection, twins and infants born to mothers who injected drugs. In turn, her team conducted an additional analysis involving all live births to HIV-positive women participating in the French ANRS Perinatal Cohort between 1996 and 2000, after excluding babies born with HIV infection, twins and infants born to mothers who injected drugs.  

It turned out that babies born to women who used ARV therapy were no more likely to be delivered preterm or underweight compared with those born to women who did not use HIV treatment during pregnancy. The HIV-positive women were, however, about twice as likely to deliver low birth weight babies compared with women in the general population in France.

The authors acknowledge that their data may be difficult to generalize, as they did not collect information on alcohol use, smoking and economic status before 2005. Since all of these factors are associated with preterm deliveries and low birth weight, and were not factored into the analysis, it is not possible to say how they may have influenced the results of the study.

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Featured Video
Do you believe we can end AIDS? To find out how you can help, click here.
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS


    blue_water
    New York City
    New York


    UPPinAction
    New Brunswick
    New Jersey


    MascGeek
    Houston
    Texas


    burke42
    Albany
    New York
Click here to join POZ Personals!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.